Procyon Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-794
| Closed | -$345K | – | 504 |
|
|
2025
Q1 | $345K | Sell |
794
-610
| -43% | -$265K | 0.02% | 456 |
|
|
2024
Q4 | $518K | Sell |
1,404
-474
| -25% | -$175K | 0.03% | 320 |
|
|
2024
Q3 | $977K | Buy |
1,878
+1
| +0.1% | +$520 | 0.07% | 236 |
|
|
2024
Q2 | $1.02M | Buy |
1,877
+20
| +1% | +$10.8K | 0.08% | 218 |
|
|
2024
Q1 | $963K | Sell |
1,857
-13
| -0.7% | -$6.74K | 0.07% | 227 |
|
|
2023
Q4 | $882K | Buy |
1,870
+168
| +10% | +$79.2K | 0.07% | 221 |
|
|
2023
Q3 | $741K | Buy |
1,702
+1,130
| +198% | +$492K | 0.08% | 242 |
|
|
2023
Q2 | $254K | Sell |
572
-90
| -14% | -$40K | 0.03% | 385 |
|
|
2023
Q1 | $304K | Sell |
662
-50
| -7% | -$23K | 0.05% | 310 |
|
|
2022
Q4 | $365K | Buy |
+712
| New | +$365K | 0.07% | 260 |
|
|
2020
Q3 | – | Sell |
-242
| Closed | -$64K | – | 422 |
|
|
2020
Q2 | $64K | Buy |
242
+146
| +152% | +$38.6K | 0.03% | 340 |
|
|
2020
Q1 | $22K | Buy |
96
+54
| +129% | +$12.4K | 0.01% | 465 |
|
|
2019
Q4 | $13K | Buy |
+42
| New | +$13K | 0.01% | 582 |
|